DiagnaMed Appoints New CEO as It Expands Hydrogen Tech Leadership with QIMC

DiagnaMed Holding Corp. (CSE: DMED) has taken a bold strategic step by appointing John Karagiannidis as its new President, CEO, and Director. Karagiannidis—who also leads Quebec Innovative Materials Corp. (QIMC)—brings unified leadership to a growing collaboration between the two firms. This move reinforces DiagnaMed’s focus on scaling its proprietary hydrogen extraction technology and advancing its role as a tech-first player in the natural hydrogen space.

As Ontario rolls out an additional $30 million through its Hydrogen Innovation Fund, DiagnaMed is poised to capitalize. With recent natural hydrogen claims in the resource-rich Temiscamingue district, and advanced R&D partnerships with QIMC and INRS, the company is accelerating efforts to integrate its technology into real-world exploration.

This new leadership structure enables faster execution, deeper resource sharing, and a streamlined strategy across multiple jurisdictions, including Ontario, Nova Scotia, and targeted regions in the U.S. Karagiannidis’s dual role is expected to unlock operational synergy, helping DiagnaMed scale its impact and commercialize clean hydrogen more effectively.

With its cutting-edge technology and sharpened leadership, DiagnaMed is now positioned as both an explorer and technology enabler at the forefront of the hydrogen transition.

Full press release can be found below.